Tag: AI Drug Discovery
Insilico nominates an AI-designed obesity pill with a safety edge
The Hong Kong-listed biotech used its generative chemistry platform to design ISM1354, a small-molecule GIPR antagonist built for obesity and…
Four pharma giants pool antibodies to train a developability AI
AbbVie, argenx, Lundbeck and Takeda are contributing proprietary antibody sequences to a shared dataset aimed at predicting which drug candidates…
Talus skips protein folding to screen 3.4 billion compounds
A Seattle startup says its structure-free model matches drugs to hard targets in milliseconds, sidestepping a blind spot in folding…
A first patient receives Generate’s AI-designed cell therapy for ovarian cancer
Generate Biomedicines and Roswell Park have dosed the first patient with GB-5267, an armored CAR T built with AI to…
DeepMind buries a verifiable marker inside AI-made proteins
Google DeepMind's SynthID Bio hides a detectable signature in AI-designed proteins without changing how they work.
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.
BioMarin enlists an AI lab to hunt for new enzyme therapies
The Emeryville lab will use its protein language models to generate enzyme candidates that BioMarin screens and can advance toward…
Microsoft builds a world model to map biology before the lab
Microsoft Research's Quine links biology models, lab tools and published literature into one loop that already surfaced tumor-shifting compounds.